0000920527-12-000002.txt : 20120103 0000920527-12-000002.hdr.sgml : 20120102 20120103145151 ACCESSION NUMBER: 0000920527-12-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120103 FILED AS OF DATE: 20120103 DATE AS OF CHANGE: 20120103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KESLER DELORES P CENTRAL INDEX KEY: 0000940671 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23832 FILM NUMBER: 12501529 MAIL ADDRESS: STREET 1: 4345 SOUTHPOINT BLVD. CITY: JACKSONVILLE STATE: FL ZIP: 32216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PSS WORLD MEDICAL INC CENTRAL INDEX KEY: 0000920527 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 592280364 STATE OF INCORPORATION: FL FISCAL YEAR END: 0327 BUSINESS ADDRESS: STREET 1: 4345 SOUTHPOINT BLVD STREET 2: STE 250 CITY: JACKSONVILLE STATE: FL ZIP: 32216 BUSINESS PHONE: 9043323000 MAIL ADDRESS: STREET 1: 4345 SOUTHPOINT BLVD STREET 2: STE 250 CITY: JACKSONVILLE STATE: FL ZIP: 32216 FORMER COMPANY: FORMER CONFORMED NAME: PHYSICIAN SALES & SERVICE INC /FL/ DATE OF NAME CHANGE: 19940318 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2012-01-03 0000920527 PSS WORLD MEDICAL INC PSSI 0000940671 KESLER DELORES P 4345 SOUTHPOINT BLVD JACKSONVILLE FL 32216 1 0 0 0 Common Stock 2012-01-03 4 M 0 25991 6.84 A 106479 D Common Stock 2012-01-03 4 S 0 25991 25.0358 D 80488 D Common Stock 6940 I by Spouse Non Qualified Stock Option (right to buy) 6.84 2012-01-03 4 M 0 25991 0 D 2003-01-02 2013-01-02 Common Stock 25991 0 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2011. This transaction was executed in multiple trades at prices ranging from $25 to $25.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option became 100% exercisable on the date of grant. Mark Rotondaro, attorney-in-fact 2012-01-03